Prof Research published a new report on Caffeine Market. It presents the largest 8 manufacturers in Caffeine Market. The report is a professional and in-depth study of the current state of the global Caffeine market. The report provides key statistics on the market of Caffeine. It is a valuable source of guidance and direction for companies and individuals interested in the Caffeine industry.

The global Caffeine market was valued to be 647.69 million USD in 2022. The Caffeine production value is anticipated to have growth with a CAGR of 2.12% in the coming years to reach 734.57 million USD in 2028.

CSPC Innovation is the largest manufacturer of Caffeine in the world, and it has a market share of 22.7% in value. CSPC Innovation Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of functional foods. The Company's main products include caffeine products, vitamin products and other functional foods.

BASF is the second largest manufacturer of Caffeine in the world, and it has a market share of 21.9% in value. BASF SE is a Germany-based chemical company. The Company operates through six segments, which include Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions.

Shandong Xinhua is the third largest manufacturer of Caffeine in the world, and it has a market share of 14.1% in value. SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets.

SJZ No.4 Pharmaceutical is the fourth largest manufacturer of Caffeine in the world, and it has a market share of 8.7% in value. SJZ No.4 Pharmaceutical (SSY Group Limited) is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products and medical packaging materials.